产品名称
单克隆抗-谷氨酸脱羧酶 67（GAD67） 小鼠抗, clone K-87, purified antibody
biological source
mouse
Quality Level
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
K-87, monoclonal
mol wt
antigen 67 kDa
species reactivity
rat, mouse, human
concentration
~1 mg/mL
technique(s)
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:500-1:20,000 (with antigen-retrieval step), western blot: 1:500-1:20,000 using mouse brain extract
isotype
IgG1κ
UniProt accession no.
shipped in
dry ice
storage temp.
−70°C
target post-translational modification
unmodified
Gene Information
human ... GAD1(2571)
mouse ... Gad1(14415)
rat ... Gad1(24379)
General description
谷氨酸脱羧酶67（GAD67）由基因谷氨酸脱羧酶1（GAD1）编码。GAD1基因位于人染色体2q31.1。GAD67位于树突和细胞体。
Immunogen
来自小鼠 GAD67 的合成肽（氨基酸 87-106）。
该肽与 GAD65 不具有同源性。
Application
小鼠抗谷氨酸脱羧酶67（GAD67）单克隆抗体已被用于：
- 免疫组织荧光
- 蛋白质印迹
- 免疫组织化学。
抗谷氨酸脱羧酶 67（GAD67）单克隆抗体适用于免疫印迹、免疫印迹（1：500-1：20,000 稀释，小鼠脑提取物）和免疫组化（1：500-1：20,000 稀释，小鼠脑切片）。
Biochem/physiol Actions
与 GAD67 特异性反应。不与 GAD65 发生交叉反应。
谷氨酸脱羧酶67（GAD67）涉及 γ-氨基丁酸 (GABA)的生产，氨基丁酸是中枢神经系统 (CNS)中的一种抑制性神经递质。GAD67缺乏会导致精神病、精神分裂和双向情感障碍。
Physical form
在含有 0.01％ 叠氮化钠的磷酸盐缓冲盐水中的溶液。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Still not finding the right product?
存储类别
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
法规信息
常规特殊物品
低风险生物材料
此项目有
Baohu Ji et al.
Human molecular genetics, 23(21), 5683-5705 (2014-06-09)
The t(1; 11) translocation appears to be the causal genetic lesion with 70% penetrance for schizophrenia, major depression and other psychiatric disorders in a Scottish family. Molecular studies identified the disruption of the disrupted-in-schizophrenia 1 (DISC1) gene by chromosome translocation
Baohu Ji et al.
PloS one, 8(6), e66327-e66327 (2013-07-05)
It has been well established that schizophrenia patients display impaired NMDA receptor (NMDAR) functions as well as exacerbation of symptoms in response to NMDAR antagonists. Abnormal NMDAR signaling presumably contributes to cognitive deficits which substantially contribute to functional disability in
Eric S Wohleb et al.
The Journal of clinical investigation, 126(7), 2482-2494 (2016-06-09)
Major depressive disorder (MDD) is a recurring psychiatric illness that causes substantial health and socioeconomic burdens. Clinical reports have revealed that scopolamine, a nonselective muscarinic acetylcholine receptor antagonist, produces rapid antidepressant effects in individuals with MDD. Preclinical models suggest that
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| G5419-100UG | 04061833634691 |